Who invested in Ambros Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$125Mraised across 1 round since 2025, from 1 source

Latest round: Series A, $125MDec 2025
Investors: 3

See who backed them

The rounds

Dec 2025
Series A$125M
Source recorded

Founders and team

From Ambros Therapeutics's own website: 4 on the team.

Jay HaganAmbros Therapeutics Chief Executive Officer
Cris CalsadaChief Financial Officer
Christopher AkerGeneral Counsel
Keith KatkinChairman of Ambros Therapeutics

Everyone who backed them

RA Capital ManagementPrivate equity1round

Janus Henderson InvestorsPrivate equity1round

Adage Capital ManagementAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ambros Therapeutics

Who invested in Ambros Therapeutics?

Ambros Therapeutics's investors include RA Capital Management, Janus Henderson Investors and Adage Capital Management.

How much has Ambros Therapeutics raised?

Ambros Therapeutics has raised $125M across 1 round since 2025.

When did Ambros Therapeutics last raise?

Ambros Therapeutics's most recent round was a Series A of $125M in Dec 2025.

What was Ambros Therapeutics's biggest round?

Its most recent round, $125M in Dec 2025, is also its largest on record.

Who backed Ambros Therapeutics first?

Ambros Therapeutics's first round on record, in Dec 2025, was backed by RA Capital Management, Janus Henderson Investors and Adage Capital Management.